Molecules 2020, 25, 1088
19 of 19
11. Brunetti, J.; Pillozzi, S.; Falciani, C.; Depau, L.; Tenori, E.; Scali, S.; Lozzi, L.; Pini, A.; Arcangeli, A.;
Menichetti, S.; et al. Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the
drug. Sci. Rep. 2015, 5, 17736.
12. Falciani, C.; Brunetti, J.; Lelli, B.; Ravenni, N.; Lozzi, L.; Depau, L.; Scali, S.; Bernini, A.; Pini, A.; Bracci, L.
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated
glycosaminoglycans and protein receptors. J. Med. Chem. 2013, 56, 5009–5018.
13. Falciani, C.; Fabbrini, M.; Pini, A.; Lozzi, L.; Lelli, B.; Pileri, S.; Brunetti, J.; Bindi, S.; Scali, S.; Bracci, L.
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting. Mol. Cancer
Ther. 2007, 6, 2441−2448.
14. Falciani, C.; Brunetti, J.; Pagliuca, C.; Menichetti, S.; Vitellozzi, L.; Lelli, B.; Pini, A.; Bracci, L. Design and in
vitro evaluation of branched peptide conjugates: Turning nonspecific cytotoxic drugs into tumor-selective
agents. ChemMedChem 2010, 5, 567−574.
15. Brunetti, J.; Riolo, G.; Gentile, M.; Bernini, A.; Paccagnini, E.; Falciani, C.; Lozzi, L.; Scali, S.; Depau, L.; Pini,
A.; et al. Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo
imaging. J. Nanobiotechnol. 2018, 16, 21.
16. Hascicek, C.; Gun, O. Nano drug delivery systems for ovarian cancer therapy. Integr. Cancer Sci. Ther. 2017,
4, 1–4.
17. Mohammadi, R.; Shokri, B.; Shamshirian, D.; Zarghi, A.; Shahhosseini, S. Synthesis and biological
evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [99mTc] via N4(GGAG)
for αVβ3 integrin-targeted drug delivery. DARU J. Pharm. Sci. 2019, 1–10. doi:10.1007/s40199-019-00318-8.
18. Zhan, H.; Zhao, H.; Muhammad, N.; Li, T.; Liu, Y.; Wang, J. Lytic peptide-grafted beta-cyclodextrin
polymer based nano-scaled drug delivery system with enhanced camptothecin anti-cancer efficacy.
Nanotechnology 2020, 31, 075101.
19. Panikar, S.S.; Ramírez-García, G.; Vallejo-Cardona, A.A.; Banu, N.; Patrón-Soberano, O.A.; Cialla-May, D.;
Camacho-Villegas, T.A.; de la Rosa, E. Novel anti-HER2 peptide-conjugated theranostic nanoliposomes
combining NaYF4:Yb,Er nanoparticles for NIR-activated bioimaging and chemo-photodynamic therapy
against breast cancer. Nanoscale 2019, 11, 20598–20613.
20. Brunetti, J.; Falciani, C.; Lelli, B.; Minervini, A.; Ravenni, N.; Depau, L.; Siena, G.; Tenori, E.; Menichetti, S.;
Pini, A.; et al. Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer. Biomed.
Res. Int. 2015, 2015, 173507.
21. Falciani, C.; Lelli, B.; Brunetti, J.; Pileri, S.; Cappelli, A.; Pini, A.; Pagliuca, C.; Ravenni, N.; Bencini, L.;
Menichetti, S.; et al. Modular branched neurotensin peptides for tumor target tracing and receptor-
mediated therapy: A proof-of-concept. Curr. Cancer Drug Targets 2010, 10, 695–704.
22. Zhang, S.; Zou, J.; Elsabahy, M.; Karwa, A.; Li, A.; Moore, D.A.; Dorshow, R.B.; Wooley, K.L. Poly(ethylene
oxide)-block-polyphosphester-based Paclitaxel Conjugates as a Platform for Ultra-high Paclitaxel-loaded
Multifunctional Nanoparticles. Chem. Sci. 2013, 4, 2122–2126.
23. Gheorghe, A.; Chinnusamy, T.; Cuevas-Yañez, E.; Hilgers, P.; Reiser, O. Combination of perfluoroalkyl and
triazole moieties: A new recovery strategy for TEMPO. Org. Lett. 2008, 10, 4171–4174.
24. Deschamps, J.; Langlois, A.; Martin, G.; Bucher, L.; Desbois, N.; Gros, C.P.; Harvey, P.D.
Cyclotriveratrylene-Containing Porphyrins. Inorg. Chem. 2016, 55, 9230–9239.
25. Liu, D.-Z.; Sinchaikul, S.; Vasu, P.; Reddy, G.; Chang, M.-Y.; Chen, S.-T. Synthesis of 2’-paclitaxel methyl 2-
glucopyranosyl succinate for specific targeted delivery to cancer cells. Bioorganic Med. Chem. Lett. 2007, 17,
617–620.
26. Lim, J.; Simanek, E.E. Synthesis of water-soluble dendrimers based on melamine bearing 16 paclitaxel
groups. Org. Lett. 2008, 10, 201–204.
Sample Availability: Samples of the compounds are not available from the authors.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).